Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

In the Literature

  • Article

    Should We Aim Higher? Actively Targeting High-Normal Potassium Levels Reduces Ventricular Arrhythmia Events and Hospitalizations in High-Risk Patients

    May 1, 2026

    Clinical question: Does a treatment strategy targeting high-normal plasma potassium levels (4.5 to 5.0 mmol/L) reduce the risk of ventricular arrhythmias and cardiovascular events in high-risk...

  • Article

    Antibiotic De-Escalation in Adults Hospitalized for Community- Onset Sepsis Without Evidence of Multidrug-Resistant Infection Is Safe

    May 1, 2026

    Clinical question: In patients hospitalized with community-onset sepsis, does empiric broad-spectrum antibiotic (BSA) de-escalation (on encounter day four), compared with continuation, affect...

  • Article

    Response to Blood Culture Shortage Promotes High Value Care

    May 1, 2026

    Clinical question: Do diagnostic stewardship interventions in times of crisis lead to sustained change in blood-culture ordering practices? Background: It is estimated that a third of all blood...

  • Article

    Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk: The TOP Randomized Clinical Trial

    May 1, 2026

    Clinical question: Does a liberal transfusion strategy decrease the risk of death or major ischemic events after major surgical operations in patients at high risk of cardiac events? Background:...

  • Article

    Predicting Contrast-Associated AKI

    May 1, 2026

    Clinical question: Do newer prediction models pooled in a systematic review predict contrast-associated acute kidney injury (CA-AKI)? Background: This systematic review updates a previous evaluation...

  • Article

    Using Biomarkers to Guide Antibiotic Duration in Suspected Sepsis

    May 1, 2026

    Clinical question: Can using daily biomarker-guided protocols, procalcitonin (PCT), or C-reactive protein (CRP) to guide antibiotic duration in adults hospitalized with sepsis safely reduce...

  • Article

    Sodium Bicarbonate Does Not Reduce 90-Day Mortality in Severe Metabolic Acidemia with AKI

    May 1, 2026

    Clinical question: In critically ill adults with severe metabolic acidemia and moderate to severe acute kidney injury (AKI), does intravenous sodium bicarbonate reduce 90-day all-cause...

  • Article

    Anticoagulation and Antiplatelet Therapy in Patients with AF and Atherosclerosis

    April 6, 2026

    CLINICAL QUESTION: In patients with atherosclerotic disease and concurrent atrial fibrillation, does adding antiplatelet therapy to oral anticoagulation improve net clinical outcomes compared with...

  • Article

    Impact of Long-Term Beta-Blocker Therapy on Death and Recurrent MI in Patients with Acute MI with Preserved Ejection Fraction

    April 6, 2026

    CLINICAL QUESTION: Does therapy with a beta-blocker reduce mortality and myocardial infarction (MI) in patients with a recent myocardial infarction with preserved ejection fraction? BACKGROUND: The...

  • Article

    Caffeinated Coffee Consumption Reduces AF Recurrence After Electrical Cardioversion

    April 6, 2026

    CLINICAL QUESTION: What effect does coffee consumption have on atrial fibrillation (AF) after successful electrical cardioversion? BACKGROUND: Coffee is one of the most-consumed beverages, and it...

Previous1 2 3 4 5 … 37Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences